79
Participants
Start Date
June 29, 2023
Primary Completion Date
March 26, 2026
Study Completion Date
March 26, 2026
Cannabidiol Oral Solution [Epidiolex]
100 mg/ml Cannabidiol Oral solution
University of Virginia, Charlottesville, Charlottesville
Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
University of Florida Health - Department of Neurology, Gainesville
Nicklaus Children's Health, Miami, Miami
Le Bonheur Children's Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Minnesota Epilepsy Group, Roseville
University of Texas Health Science Center at Houston - Clinical Research Unit, Houston
University of Texas Health Science Center - San Antonio, San Antonio
Children's Hospital Colorado, Aurora
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Alberta Children's Hospital, Calgary
BC Children's Hospital, Vancouver
The Hospital for Sick Children, Toronto
The Children's Memorial Health Institute, Warsaw
Evelina London Children's Hospital Guys St Thomas' NHS Foundation Trust, the Guy's Hospital, London
University Hospitals Bristol NHS Foundation Trust, Bristol
Sheffield Children's NHS Foundation Trust, Sheffield
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY